FiercePharma1d
Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
Revolutionary non-opioid painkiller Journavx set to hit pharmacies soon
It's the first new type of painkiller in 20 years. And it's just a few weeks away from being here in local pharmacies.
Chemistry World2d
New type of painkiller approved in US
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
Healthcare Dive1d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
BioSpace5d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
fingerlakes14d
FDA approves first new non-opioid painkiller in 20 years
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment
SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 /CenExel, a leading network of clinical research sites, proudly ...
Miami Herald6d
CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment
"The approval of JOURNAVX represents a monumental step forward in acute pain treatment," said Ryan Brooks, Chief Executive Officer of CenExel. "For decades, the industry has been searching for a ...